Bobbie Pharmaceutical Services SRL
Bobbie Pharmaceutical Services reported revenue of €1.53m for the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026).
The score of Bobbie Pharmaceutical Services shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bobbie Pharmaceutical Services's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Mar 2024filed on 26 Sep 2024
Bobbie Pharmaceutical Services's financial analysis
- Solvency37.3%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bobbie Pharmaceutical Services
15 active director(s) in the register.
and 9 more
Bobbie Pharmaceutical Services's shareholders and holdings →Bobbie Pharmaceutical Services's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0799.344.237
- VAT number
- BE0799344237
- Peppol
- Registered · 0208:0799344237 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Mar 2023
- Registered office
- 8750 Wingene
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Bobbie Pharmaceutical Services (SRL) has been based in Wingene since 2023, active in: activities of holding companies. For 2025, it reports revenue of €1.53m, a net loss of €1.15m and equity of €17.5m. Its solvency stands at 37.3%, below the median of its sector (55.6%).
Companies similar to Bobbie Pharmaceutical Services
Companies in the same business, of comparable size and area, outside its group.
- GDW Group Activities of holding companies Waregem · balance sheet €41.6m
- Trenker HoldCo Activities of holding companies Ghent · balance sheet €36.4m
- AMO Business and other management consultancy activities Stabroek · balance sheet €30.9m
- United NRJ Activities of head offices Moorslede · balance sheet €53.6m
- JM Capital Activities of holding companies Ranst · balance sheet €23.2m
- SL Corporate Activities of holding companies Nazareth-De Pinte · balance sheet €41.1m
- Financiere SUD Sante Activities of holding companies Etterbeek · balance sheet €101.9m
- Thaly Business and other management consultancy activities Brussels · balance sheet €104.9m
Frequently asked questions about Bobbie Pharmaceutical Services
What is the revenue of Bobbie Pharmaceutical Services?
According to the 2025 annual accounts filed with the NBB, the revenue of Bobbie Pharmaceutical Services amounts to 1,528,333 €.
What is the VAT number of Bobbie Pharmaceutical Services?
In Belgium, the VAT number is the company number prefixed with BE: BE0799344237 for Bobbie Pharmaceutical Services, if the company is VAT-registered. Its company number (CBE) is 0799.344.237.
Where is the registered office of Bobbie Pharmaceutical Services?
According to the CBE register, the registered office of Bobbie Pharmaceutical Services is in 8750 Wingene.
What is the equity of Bobbie Pharmaceutical Services?
At the close of the 2025 financial year, the equity of Bobbie Pharmaceutical Services amounts to 17,506,021 €, a solvency of 37.3% of total assets.
Who manages Bobbie Pharmaceutical Services?
The register lists 15 active mandates at Bobbie Pharmaceutical Services. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bobbie Pharmaceutical Services
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →